Jürgen Pannek1, Susanne Pannek-Rademacher2, Mohinder S Jus3, Jens Wöllner1, Jörg Krebs4. 1. a Neuro-Urology , Swiss Paraplegic Centre , Nottwil , Switzerland. 2. b Homöopathie-Pannek , Basel , Switzerland. 3. c SHI Homöopathische Praxis , Zug , Switzerland. 4. d Clinical Trial Unit , Swiss Paraplegic Centre , Nottwil , Switzerland.
Abstract
Context/Objective: to investigate the usefulness of classical homeopathy for the prevention of recurrent urinary tract infections (UTI) in patients with spinal cord injury (SCI). Design: prospective study. Setting: rehabilitation center in Switzerland. Participants: patients with chronic SCI and ≥3 UTI/year. Interventions: Participants were treated either with a standardized prophylaxis alone or in combination with homeopathy. Outcome measures: The number of UTI, general and specific quality of life (QoL), and satisfaction with homeopathic treatment were assessed prospectively for one year. Results: Ten patients were in the control group; 25 patients received adjunctive homeopathic treatment. The median number of self-reported UTI in the homeopathy group decreased significantly, whereas it remained unchanged in the control group. The domain incontinence impact of the KHQ improved significantly (P = 0.035), whereas the general QoL did not change. The satisfaction with homeopathic care was high. Conclusions: Adjunctive homeopathic treatment lead to a significant decrease of UTI in SCI patients. Therefore, classical homeopathy could be considered in SCI patients with recurrent UTI. Trial registration: ClinicalTrials.gov. (NCT01477502).
Context/Objective: to investigate the usefulness of classical homeopathy for the prevention of recurrent urinary tract infections (UTI) in patients with spinal cord injury (SCI). Design: prospective study. Setting: rehabilitation center in Switzerland. Participants: patients with chronic SCI and ≥3 UTI/year. Interventions: Participants were treated either with a standardized prophylaxis alone or in combination with homeopathy. Outcome measures: The number of UTI, general and specific quality of life (QoL), and satisfaction with homeopathic treatment were assessed prospectively for one year. Results: Ten patients were in the control group; 25 patients received adjunctive homeopathic treatment. The median number of self-reported UTI in the homeopathy group decreased significantly, whereas it remained unchanged in the control group. The domain incontinence impact of the KHQ improved significantly (P = 0.035), whereas the general QoL did not change. The satisfaction with homeopathic care was high. Conclusions: Adjunctive homeopathic treatment lead to a significant decrease of UTI in SCI patients. Therefore, classical homeopathy could be considered in SCI patients with recurrent UTI. Trial registration: ClinicalTrials.gov. (NCT01477502).
Authors: Benedikt Brommer; Odilo Engel; Marcel A Kopp; Ralf Watzlawick; Susanne Müller; Harald Prüss; Yuying Chen; Michael J DeVivo; Felix W Finkenstaedt; Ulrich Dirnagl; Thomas Liebscher; Andreas Meisel; Jan M Schwab Journal: Brain Date: 2016-01-10 Impact factor: 13.501
Authors: Rabih O Darouiche; Bruce G Green; William H Donovan; David Chen; Michael Schwartz; John Merritt; Michelle Mendez; Richard A Hull Journal: Urology Date: 2011-06-17 Impact factor: 2.649
Authors: Giuseppe Quarto; Riccardo Autorino; Antonio Gallo; Marco De Sio; Massimo D'Armiento; Sisto Perdonà; Rocco Damiano Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2006-05-13
Authors: Jan Groen; Jürgen Pannek; David Castro Diaz; Giulio Del Popolo; Tobias Gross; Rizwan Hamid; Gilles Karsenty; Thomas M Kessler; Marc Schneider; Lisette 't Hoen; Bertil Blok Journal: Eur Urol Date: 2015-08-22 Impact factor: 20.096
Authors: L L Goetz; D D Cardenas; M Kennelly; B S Bonne Lee; T Linsenmeyer; C Moser; J Pannek; J-J Wyndaele; F Biering-Sorensen Journal: Spinal Cord Date: 2013-07-30 Impact factor: 2.772
Authors: Denise G Tate; Tracey Wheeler; Giulia I Lane; Martin Forchheimer; Kim D Anderson; Fin Biering-Sorensen; Anne P Cameron; Bruno Gallo Santacruz; Lyn B Jakeman; Michael J Kennelly; Steve Kirshblum; Andrei Krassioukov; Klaus Krogh; M J Mulcahey; Vanessa K Noonan; Gianna M Rodriguez; Ann M Spungen; David Tulsky; Marcel W Post Journal: J Spinal Cord Med Date: 2020-03 Impact factor: 1.985